Showing results (521-530 of 542) with videos related to

Sort By:
Pageof 55
Health Technology Assessment (Winchester, England)|December 20, 2019
3-month versus 6-month adjuvant chemotherapy for patients with high-risk stage II and III colorectal cancer: 3-year follow-up of the SCOT non-inferiority RCTTimothy Iveson, Kathleen A Boyd, Rachel S Kerr, et al.
The Lancet. Gastroenterology & Hepatology|December 15, 2022
Immediate surgery compared with short-course neoadjuvant gemcitabine plus capecitabine, FOLFIRINOX, or chemoradiotherapy in patients with borderline resectable pancreatic cancer (ESPAC5): a four-arm, multicentre, randomised, phase 2 trialPaula Ghaneh, Daniel Palmer, Silvia Cicconi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 27, 2023
Pathologic Lymph Node Regression After Neoadjuvant Chemotherapy Predicts Recurrence and Survival in Esophageal Adenocarcinoma: A Multicenter Study in the United KingdomJonathan L Moore, Michael Green, Aida Santaolalla, et al.
Nature Communications|November 19, 2021
Modulation of pancreatic cancer cell sensitivity to FOLFIRINOX through microRNA-mediated regulation of DNA damagePietro Carotenuto, Francesco Amato, Andrea Lampis, et al.
World Journal of Surgery|January 9, 2019
Unifying Children's Surgery and Anesthesia Stakeholders Across Institutions and Clinical Disciplines: Challenges and Solutions from UgandaPhyllis Kisa, David F Grabski, Doruk Ozgediz, et al.
The Lancet. Digital Health|August 21, 2021
Development and validation of deep learning classifiers to detect Epstein-Barr virus and microsatellite instability status in gastric cancer: a retrospective multicentre cohort studyHannah Sophie Muti, Lara Rosaline Heij, Gisela Keller, et al.
The Journal of Pathology|November 15, 2023
Genetic and immune landscape evolution in MMR-deficient colorectal cancerBenjamin R Challoner, Andrew Woolston, David Lau, et al.
JAMA Surgery|September 5, 2019
Patterns of Recurrence After Resection of Pancreatic Ductal Adenocarcinoma: A Secondary Analysis of the ESPAC-4 Randomized Adjuvant Chemotherapy TrialRobert P Jones, Eftychia-Eirini Psarelli, Richard Jackson, et al.
Health Technology Assessment (Winchester, England)|February 7, 2018
PET-PANC: multicentre prospective diagnostic accuracy and health economic analysis study of the impact of combined modality 18fluorine-2-fluoro-2-deoxy-d-glucose positron emission tomography with computed tomography scanning in the diagnosis and management of pancreatic cancerPaula Ghaneh, Robert Hanson, Andrew Titman, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|May 5, 2026
The density of tumour infiltrating lymphocytes in oesophago-gastric cancer varies with disease stage, geographical region and treatment: a post hoc analysis of nine phase III clinical trialsGeorgina A Keogh, Nina Šefčovičová, Tomio Arai, et al.
Pageof 55